voriconazole has been researched along with chondroitin sulfates in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dahl, P; Hu, DN; Koplin, RS; Meskin, SW; Perez, W; Ritterband, DC; Seedor, JA; Shah, MK; Yang, R | 1 |
| Kim, SY; Lee, YC; Yang, J | 1 |
| Cevallos, V; Hoover, C; Jeng, BH; Keenan, JD; Layer, N; Maxwell, AJ | 1 |
3 other study(ies) available for voriconazole and chondroitin sulfates
| Article | Year |
|---|---|
Efficacy and safety of voriconazole as an additive in Optisol GS: a preservation medium for corneal donor tissue.
Topics: Antifungal Agents; Cell Count; Cell Survival; Chondroitin Sulfates; Complex Mixtures; Cornea; Culture Media, Serum-Free; Dextrans; Drug Combinations; Endothelium, Corneal; Fungi; Gentamicins; Humans; Middle Aged; Organ Preservation; Organ Preservation Solutions; Pyrimidines; Tissue Donors; Treatment Outcome; Triazoles; Voriconazole | 2007 |
Safety of moxifloxacin and voriconazole in corneal storage media on porcine corneal endothelial cells.
Topics: Animals; Anti-Infective Agents; Aza Compounds; Cell Count; Cell Survival; Chondroitin Sulfates; Complex Mixtures; Cornea; Cryopreservation; Culture Media, Serum-Free; Dextrans; Endothelium, Corneal; Fluoroquinolones; Gentamicins; Moxifloxacin; Organ Preservation Solutions; Pyrimidines; Quinolines; Swine; Tissue Preservation; Triazoles; Voriconazole | 2010 |
Efficacy and safety of antifungal additives in Optisol-GS corneal storage medium.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Candida glabrata; Candidiasis; Cell Count; Chondroitin Sulfates; Colony Count, Microbial; Complex Mixtures; Cornea; Culture Media, Serum-Free; Dextrans; Drug Combinations; Drug Contamination; Endothelium, Corneal; Gentamicins; Humans; Microbial Sensitivity Tests; Organ Preservation; Organ Preservation Solutions; Pyrimidines; Tissue Donors; Treatment Outcome; Triazoles; Voriconazole | 2014 |